Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
AAAS Promotion

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 25 June 1999:
Vol. 284. no. 5423, p. 2066
DOI: 10.1126/science.284.5423.2066a
Prev | Table of Contents | Next

News of the Week

GENE THERAPY:
RAC Urges Changes to Retinoblastoma Plan

Ken Garber

The Recombinant DNA Advisory Committee (RAC) lost its approval authority over gene therapy protocols 2 years ago, but now may be regaining its clout. Last week the committee turned thumbs down on a gene therapy protocol for treating retinoblastoma, a rare childhood cancer of the eye--and the lead investigator listened. Also last week, RAC got a strong endorsement from National Institutes of Health director Harold Varmus, who 3 years ago proposed doing away with the committee but then, in response to much protest, agreed to keep it to advise on policy matters.

Read the Full Text

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)